Pharmafile Logo
Pharmafocus logo
Advanced Search
abpi_reception

Ten pharma firms censured

March 28, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA

Ten pharma companies have been found guilty by the PMCPA of failing to maintain high standards over their involvement in …

News
FDA image

US nod for Tecfidera

March 28, 2013
Sales and Marketing Biogen, FDA, tecfidera

The FDA has given Biogen Idec’s oral multiple sclerosis treatment Tecfidera the green light. Earlier this week Tecfidera (dimethyl fumarate) …

News

Star commercial academy appoints director

March 28, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Star

Gary Lunt has been appointed to the newly created role of Business Development director with training agency STAR Commercial Academy. …

Appointment

New ‘culture of compassion’ for NHS

March 27, 2013
Sales and Marketing Francis, Francis report, Hunt, Mid Staffs, NHS, Staffs

The government has launched plans to ensure that the needs of patients are paramount in any future dealings with the …

News
GSK image

FDA delays GSK flu vaccine

March 27, 2013
Research and Development, Sales and Marketing FDA, GSK, Vaccine

The FDA has cooled on GlaxoSmithKline’s latest vaccine for a bird flu pandemic, Q-Pan H5N1, despite a vote of confidence …

News
biogen idec image

Multiple sclerosis rivals gain EU approval

March 27, 2013
Research and Development, Sales and Marketing Biogen IDEC, Genzyme, MS

Rival MS treatments from Biogen Idec and Genzyme have both received European approval. The CHMP has recommended marketing authorisation for …

News
stuart_mcguire_12a

Chiltern announces two promotions

March 26, 2013
Manufacturing and Production, Research and Development, Sales and Marketing chiltern

Global clinical contract research organisation Chiltern International has announced the promotions of Stuart McGuire and Jim Szymeczek.“I am pleased to …

Appointment
crestor image

AstraZeneca settles Crestor case

March 26, 2013
Sales and Marketing AstraZeneca, Crestor, Watson

AstraZeneca has settled a long-running legal battle over one of its biggest brands, Crestor, whose patent expires in 2016. The …

News
sanofi image

Sanofi in immunotherapy tie-up

March 26, 2013
Research and Development, Sales and Marketing Transgene, snaofi

Sanofi has signed a 15-year deal with biopharma company Transgene to produce a platform to help create a range of …

News

Africa rising

March 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Lunt

Africa has been a byword for poverty, disease and political turmoil for generations, and many people in the most developed …

Feature

New chief executive for Eyevensys

March 26, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Eyevensys

Gene therapy development firm Eyevensys has announced the appointment of Dr Ivan Cohen-Tanugi as chief executive.Cohen-Tanugi has over 20 years’ …

Appointment
Xarelto image

Xarelto gets EU nod

March 25, 2013
Sales and Marketing Bayer, Xarelto

Bayer HealthCare has been given a boost by the recommendation in Europe of its oral blood thinner Xarelto to prevent …

News
mike_williams_leo_pharma

LEO Pharma appoints two divisional directors

March 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LEO Pharma

LEO Pharma has made two new appointments to the leadership team of its UK/Ireland affiliate.Mike Williams (pictured) joins to head …

Appointment

AstraZeneca hires strategy boss

March 25, 2013
Sales and Marketing AstraZeneca, dunoyer

AstraZeneca has poached one of GlaxoSmithKline’s senior executives to help push through its new growth strategy. Marc Dunoyer, global head …

News

Actavis to invest in Florida facility

March 25, 2013
Manufacturing and Production Actavis, Watson

Actavis has announced a $40.5 million investment round at its plant in Davie, Florida, that looks set to create around …

News

Two Apotex facilities cited by FDA

March 25, 2013
Manufacturing and Production Apotex, FDA

Canadian generic drugmaker Apotex has been sent another warning letter by the FDA after violations were uncovered at two manufacturing …

News

Contract research news in brief

March 22, 2013
Research and Development Calvert labs, Frontage Labs, Medrio, Mytrus, Particle Sciences, Sotio, chiltern, inVentiv Health

inVentiv takes stake in Mytrus, Frontage Labs FDA-inspected, plus updates from Chiltern, Calvert Labs/Particle Sciences and Medrio.

News

Pharma manufacturing news in brief

March 22, 2013
Manufacturing and Production APIC, Agila, Avitide, Catalent, Contego, Malaysian Bio-XCell, Nueland Labs, ShangPharma, Zhejiang biotech

Agila to build a new facility in Malaysia, Avitide raises money for new bioprocessing technology, plus alliance and acquisition news …

News

Merck KGaA/BMS China deal

March 22, 2013
Sales and Marketing BMS, Merck KGaA, diabetes

Merck KGaA and Bristol-Myers Squibb are to co-promote the German firm’s veteran diabetes drug Glucophage in different formations in China. …

News
rachel_flavell

Two new appointments at PAN

March 22, 2013
Medical Communications, Sales and Marketing Pan, advertising

Creative agency PAN has welcomed two new team members in senior copywriter Sarah White and account manager Rachel Flavell. White …

Appointment
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026